Results
|
1821.
|
|
|
1822.
|
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer. [electronic resource] by
- Fields, K K
- Elfenbein, G J
- Perkins, J B
- Ballester, O F
- Goldstein, S C
- Heimenz, J W
- Saez, R A
- Sullivan, D M
- Partyka, J S
- Kronish, L A
Producer: 19980512
In:
Seminars in oncology vol. 25
Availability: No items available.
|
|
1823.
|
|
|
1824.
|
|
|
1825.
|
|
|
1826.
|
Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208. [electronic resource] by
- Tokuda, Yutaka
- Tajima, Tomoo
- Narabayashi, Masaru
- Takeyama, Kunihiko
- Watanabe, Toru
- Fukutomi, Takashi
- Chou, Takaaki
- Sano, Muneaki
- Igarashi, Tadahiko
- Sasaki, Yasutsuna
- Ogura, Michinori
- Miura, Shigeto
- Okamoto, Shin-ichiro
- Ogita, Masami
- Kasai, Masaharu
- Kobayashi, Tadashi
- Fukuda, Haruhiko
- Takashima, Shigemitsu
- Tobinai, Kensei
Producer: 20080215
In:
Cancer science vol. 99
Availability: No items available.
|
|
1827.
|
|
|
1828.
|
|
|
1829.
|
|
|
1830.
|
|
|
1831.
|
|
|
1832.
|
|
|
1833.
|
|
|
1834.
|
|
|
1835.
|
|
|
1836.
|
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy. [electronic resource] by
- Prince, H M
- Bashford, J
- Wall, D
- Rischin, D
- Parker, N
- Toner, G C
- Seymour, J F
- Blakey, D
- Haylock, D
- Simmons, P
- Francis, P
- Wolf, M
- Januszewicz, E H
- Richardson, G
- Scarlett, J
- Briggs, P
Producer: 20021119
In:
Cytotherapy vol. 4
Availability: No items available.
|
|
1837.
|
|
|
1838.
|
|
|
1839.
|
|
|
1840.
|
|